Web Analytics

3 Latest Announced Rounds

  • $4,200,000
    Seed

    5 Investors

    Technology, Information and Internet
    Jun 5th, 2025
  • $9,142,230
    Seed

    1 Investors

    Software Development
    Jun 5th, 2025
  • $25,000,000
    Unknown

    2 Investors

    Software Development
    Jun 5th, 2025
$883.17M Raised in 51 Funding Rounds in the past 7 Days - View All

Funding Round Profile

eGenesis, Inc.

start up
United States - Cambridge, MA
  • 04/09/2024
  • Series B
  • $191,000,000

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.

eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.


Related People

Michael CurtisFounder

Michael Curtis United States - Waltham, Massachusetts

N/A